Related Experiment Video
Updated: Jan 26, 2026

Establishment of Zebrafish Patient-Derived Xenografts from Pancreatic Cancer for Chemosensitivity Testing
Published on: May 12, 2023
Pan-cancer N-glycoproteomic atlas of patient-derived xenografts uncovers FAT2 as an actionable surface target
Meinusha Govindarajan1, Salvador Mejia-Guerrero2, Shawn C Chafe3
1Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2C1, Canada.
Abstract:
Cell surface proteins offer significant cancer therapeutic potential attributable to their accessible membrane localization and central roles in cellular signaling, yet their promise remains largely untapped due to technical challenges inherent to profiling them. Here, we employ N-glycoproteomics to analyze 85 patient-derived xenografts (PDXs), constructing Glyco PDXplorer-an in vivo pan-cancer atlas of cancer-derived surface proteins. We develop a target discovery pipeline to prioritize proteins with favorable expression profiles for immunotherapeutic targeting and validate FAT2 as a squamous-cancer-enriched surface protein minimally detected in normal tissue. Functional studies reveal that FAT2 is essential for head and neck squamous cancer (HNSC) cell growth and adhesion through regulation of surface architecture and integrin-PI3K signaling. Chimeric antigen receptor (CAR)-T cells targeting FAT2 demonstrate anti-tumor activity. This work lays the foundation for developing FAT2-targeted therapies and represents a pivotal platform to inform therapeutic target discovery across cancers.
Insights
Researchers identified FAT2 as a promising cancer target using N-glycoproteomics on patient-derived xenografts. FAT2-targeted therapies, including CAR-T cells, show anti-tumor activity, especially in squamous cell cancers.
Area of Science:
- Oncology
- Proteomics
- Immunotherapy
Background:
- Cell surface proteins are crucial for cancer signaling and therapeutic targeting.
- Profiling cell surface proteins is challenging, limiting therapeutic development.
- Patient-derived xenografts (PDXs) offer a valuable model for cancer research.
Purpose of the Study:
- To create a pan-cancer atlas of cancer-derived surface proteins using N-glycoproteomics.
- To develop a pipeline for identifying immunotherapeutic targets from surface protein profiles.
- To validate FAT2 as a potential therapeutic target for squamous cell cancers.
Main Methods:
- N-glycoproteomics analysis of 85 patient-derived xenografts (PDXs).
- Development of a target discovery pipeline for prioritizing surface proteins.
- Functional studies on FAT2 in head and neck squamous cell cancer (HNSC) models.
- Evaluation of Chimeric Antigen Receptor (CAR)-T cell therapy targeting FAT2.
Main Results:
- Glyco PDXplorer, an in vivo atlas of cancer-derived surface proteins, was constructed.
- FAT2 was identified as a squamous-cancer-enriched surface protein with minimal expression in normal tissues.
- FAT2 is essential for HNSC cell growth and adhesion via surface architecture and integrin-PI3K signaling.
- FAT2-targeted CAR-T cells demonstrated significant anti-tumor activity.
Conclusions:
- FAT2 is a validated therapeutic target for squamous cell cancers.
- The Glyco PDXplorer platform facilitates discovery of novel cancer targets.
- This work establishes a foundation for FAT2-targeted therapies and broader immunotherapeutic strategies.
Related Concept Videos
Surface Tension, Capillary Action, and Viscosity
The various IMFs between identical molecules of a substance are examples of cohesive forces. The molecules within a liquid are surrounded by other molecules and are attracted equally in all directions by the cohesive forces within the liquid. However, the molecules on the surface of a liquid are attracted only by about one-half as many molecules. Because of the unbalanced molecular attractions on the surface molecules, liquids contract to form a shape that minimizes the number...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Fixed Action Patterns
Action Potential
Membrane potential in neurons
Neurons typically have a resting membrane potential of about -70 millivolts (mV). When they receive...
Action Potential
Membrane potential in neurons
Neurons typically have a resting membrane potential of about -70 millivolts (mV). When they receive...

